| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
52,373,000 |
| Market
Cap: |
2.43(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$30.85 - $52.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 474 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
144,016 |
280,825 |
308,234 |
348,833 |
| Total Sell Value |
$6,682,454 |
$12,131,422 |
$13,114,420 |
$14,216,679 |
| Total People Sold |
6 |
7 |
7 |
7 |
| Total Sell Transactions |
12 |
28 |
34 |
37 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hopper Jonathan Mark |
Chief Medical Officer |
• • – |
2024-05-20 |
4 |
AS |
$49.99 |
$499,900 |
D/D |
(10,000) |
58,116 |
|
-7% |
|
| Hopper Jonathan Mark |
Chief Medical Officer |
• • – |
2024-05-20 |
4 |
OE |
$10.95 |
$109,500 |
D/D |
10,000 |
68,116 |
|
- |
|
| Halpin Michael |
Chief Operating Officer |
• • – |
2024-05-17 |
4 |
OE |
$2.65 |
$28,017 |
D/D |
5,195 |
6,284 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-05-16 |
4 |
AS |
$47.85 |
$837,375 |
D/D |
(17,500) |
220,752 |
|
0% |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-05-16 |
4 |
OE |
$3.02 |
$52,850 |
D/D |
17,500 |
238,252 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-05-15 |
4 |
AS |
$49.67 |
$869,225 |
D/D |
(17,500) |
220,752 |
|
-3% |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-05-15 |
4 |
OE |
$3.02 |
$52,850 |
D/D |
17,500 |
238,252 |
|
- |
|
| Hagen Heidi |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
18,650 |
|
- |
|
| Wright Lisa |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
9,017 |
|
- |
|
| Wotton Paul K |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
30,002 |
|
- |
|
| Zerbe Robert L Md |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
26,595 |
|
- |
|
| Mclaughlin Kevin F |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
11,900 |
|
- |
|
| Gilman Steven C |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
11,000 |
|
- |
|
| Rubino Alan L |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
23,794 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-04-30 |
4 |
OE |
$7.20 |
$299,977 |
D/D |
25,445 |
220,752 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-04-18 |
4 |
AS |
$44.59 |
$780,325 |
D/D |
(17,500) |
195,307 |
|
9% |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-04-18 |
4 |
OE |
$3.02 |
$52,850 |
D/D |
17,500 |
212,807 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-04-17 |
4 |
AS |
$46.47 |
$813,225 |
D/D |
(17,500) |
195,307 |
|
9% |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-04-17 |
4 |
OE |
$3.02 |
$52,850 |
D/D |
17,500 |
212,807 |
|
- |
|
| Rubino Alan L |
|
• • – |
2024-04-09 |
4 |
OE |
$4.12 |
$12,360 |
D/D |
3,000 |
20,594 |
|
- |
|
| Zerbe Robert L Md |
|
• • – |
2024-03-27 |
4 |
AS |
$51.57 |
$169,046 |
D/D |
(3,278) |
23,395 |
|
-9% |
|
| Zerbe Robert L Md |
|
• • – |
2024-03-27 |
4 |
OE |
$3.74 |
$12,260 |
D/D |
3,278 |
26,673 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-03-14 |
4 |
AS |
$44.02 |
$770,350 |
D/D |
(17,500) |
194,870 |
|
8% |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-03-14 |
4 |
OE |
$3.02 |
$52,850 |
D/D |
17,500 |
212,370 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2024-03-13 |
4 |
AS |
$44.67 |
$781,725 |
D/D |
(17,500) |
194,870 |
|
7% |
|
401 Records found
|
|
Page 1 of 17 |
|
|
1.35 (2.83%) 
